// App-Quantinova.ai

EP1187 : APPRAISAL OF THE CONSISTENT USE AND REPORTING OF PATIENT-REPORTED OUTCOMES IN MULTIPLE MYELOMA CLINICAL TRIALS: DOES IT MATTER?

Researchers

Presenter

  • Edward Laane

Principal Investigators

  • Tatyana Ionova

  • Esther Natalie Oliva

  • Marike Andreas

  • Nina Kreuzberger

  • Vanessa Piechotta

  • Ina Monsef

  • Nicole Skoetz

  • Sam Salek

Medical Centers

  • Department of Hematology and Oncology,University of Tartu,Tartu,Estland

  • School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

  • St.Petersburg State University Hospital,Saint-Petersburg,Russian Federation

  • Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

  • Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy

Locations

  • Estonia

  • United Kingdom

  • Russia

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • EORTC-MY20

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved